Vimarsana
Biggest News Aggregation in the World

Page 3 - Looking Statements News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Looking Statements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Looking Statements Today - Breaking & Trending Today

Hyatt Hotels : Announces Pricing of Public Offering of Senior Notes - Vimarsana News

Hyatt Hotels : Announces Pricing of Public Offering of Senior Notes

CHICAGO, June 3, 2024 -- Hyatt Hotels Corporation , a leading global hospitality company, announced today the pricing of its public offering of $450,000,000 aggregate principal amount of...

Hyatt Announces Pricing of Public Offering of Senior Notes - Vimarsana News

Hyatt Announces Pricing of Public Offering of Senior Notes

Hyatt Hotels Corporation , a leading global hospitality company, announced today the pricing of its public offering of $450,000,000 aggregate principal amount of senior notes due 2029, which will...

Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 ... - Vimarsana News

Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 ...

26% reduction in risk of death (HR=0.74) and 28% risk reduction in progression or death (HR=0.72) in previously-treated patients administered with CM24+nivolumab+Nal/IRI/5FU/LV vs. standard-of-care(SoC) based on preliminary interim dataProlongation of

SRQ Resources to Participate in Virtual Non-Deal Roadshow on June 3, 2024 - Vimarsana News

SRQ Resources to Participate in Virtual Non-Deal Roadshow on June 3, 2024

MONTRÉAL, QC / ACCESSWIRE / May 31, 2024 / SRQ Resources Inc. (TSXV:SRQ) ("SRQ" or the "Company") is pleased to announce that it will participate in a virtual non-deal roadshow to discuss the encouraging

SciSparc Secures Strategic Advantage with Grant of European Patent - Vimarsana News

SciSparc Secures Strategic Advantage with Grant of European Patent

TEL AVIV, Israel, May 31, 2024 -- SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central...